Skip to content

Released May 9, 2017, after the close

10-Q filed May 9, 2017, 39 days after period end · 0001162194-17-000042

Q1 2017 · 10-Q
Revenue$25.53M−12.0% vs Q1 2016+1.8% vs Q4 2016
Net Income-$17.20MN/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$0.59N/M vs Q1 2016N/M vs Q4 2016
Operating Income-$17,536,000N/M
Operating Cash Flow-$8,488,000N/M
Free Cash Flowderived-$9,180,000N/M
Margins · derived
Operating margin-68.7%−3.6 pt vs Q1 2016
Net margin-67.4%+1.2 pt vs Q1 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2017Q1 2016Q1 2015Q1 2014
Revenue$25.53M$29.00M$26.73M$25.72M
Net Income-$17.20M-$19.88M-$15.93M-$15.41M
EPS Diluted-$0.59-$0.69-$0.56-$0.57

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR